Biocon, Nobex insulin deal

Biocon (NSE:BIOCONEQ) and Nobex ( Research Triangle Park, N.C.) partnered to develop an oral insulin product to treat diabetes. The deal combines BIOCONEQ's peptide production capabilities with Nobex'...